What Every Pharma Marketer Should Know About Naming a New Drug: A

What Every Pharma Marketer Should Know About Naming a New Drug: A Conversation with Addison Whitney (Part 2)

Listen now

Description

Naming a new drug is a complex process. So much so that we needed to dedicate two episodes to the topic. Co-hosts John Hinkle and Will Brown discuss the ins and outs, and the do's and don'ts when it comes to naming drugs with two specialists: Nancy Globus and Jennifer Sirop with Addison Whitney. Nancy is VP of Regulatory and Medication Safety and Jennifer is VP of Trademarks. During this 2 episode special, we have an in-depth conversation about best practices and possible landmines to avoid when it comes to naming a new drug.

More Episodes

See all »

PharmaMarketing 411

Published 12/13/21

Becoming a Better Strategic Brand Planner: A Conversation with Janice MacLennan

Co-hosts Will Brown and John Hinkle are thrilled to welcome Janice MacLennan to this episode of PharmaMarketing 411 to have a conversation about what the pharma industry can do to improve the approach to brand strategy. We talk about how Janice has made a pivot in how she approaches marketing...

Published 12/13/21

Rx for Your Brand Plan: A Conversation with Markus Saba and Hilary Gentile

Markus Saba is Professor, Executive In Residence, at The Center for the Business of Health at UNC’s Kenen Flagler Business School, and has a wealth of experience in the pharmaceutical industry and spent 25 years with Eli Lily in numerous senior marketing leadership roles.. Hilary Gentile is the...

Published 11/29/21